Anoro Ellipta (umeclidinium and vilanterol) is a brand-name inhaler that’s prescribed for COPD. Anoro Ellipta has interactions with some other drugs, including itraconazole (Sporanox ...
Umeclidinium 62.5mcg, vilanterol 25mcg; per inhalation; dry pwd for oral inhalation. Umeclidinium is a long-acting muscarinic antagonist, which is often referred to as an anticholinergic. It has ...
Zacks.com on MSN6d
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term OutlookGSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...
Sales of its asthma and COPD medication Advair are declining, and payers are demanding more from its next generation treatments Breo and Anoro Ellipta. “Digital innovations, like sensor ...
Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva ...
Innoviva is entitled to receive royalties from GSK on sales of RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®. Innoviva’s other innovative healthcare assets include infectious disease and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback